265 related articles for article (PubMed ID: 36375238)
41. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
[TBL] [Abstract][Full Text] [Related]
42. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.
Li X; Meng Y; Xie C; Zhu J; Wang X; Li Y; Geng S; Wu J; Zhong C; Li M
J Cell Biochem; 2018 May; 119(5):4134-4141. PubMed ID: 29243835
[TBL] [Abstract][Full Text] [Related]
43. GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/β‑catenin and Notch signalling pathways.
Si Y; Li L; Zhang W; Liu Q; Liu B
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069229
[TBL] [Abstract][Full Text] [Related]
44. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.
Chan MM; Chen R; Fong D
Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048
[TBL] [Abstract][Full Text] [Related]
45. Targeting the Cancer Stem Cells in Endocrine Cancers with Phytochemicals.
Gor R; Ramachandran I; Ramalingam S
Curr Top Med Chem; 2022; 22(31):2589-2597. PubMed ID: 36380414
[TBL] [Abstract][Full Text] [Related]
46. Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling.
Kim H; Yu Y; Choi S; Lee H; Yu J; Lee JH; Kim WY
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835579
[TBL] [Abstract][Full Text] [Related]
47. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
[TBL] [Abstract][Full Text] [Related]
48. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
49. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
50. [Research progression in colorectal cancer stem cells].
Wu TY; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
[TBL] [Abstract][Full Text] [Related]
51. Phytochemicals Targeting Colorectal Cancer Growth and Metastasis.
Muppala S
Crit Rev Oncog; 2020; 25(2):141-149. PubMed ID: 33389863
[TBL] [Abstract][Full Text] [Related]
52. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic Potential of Polyphenols and their Nanoformulations in the Treatment of Colorectal Cancer.
Khan SH; Alhumaydhi FA; Khan MA; Younus H
Anticancer Agents Med Chem; 2021 Oct; 21(16):2117-2129. PubMed ID: 33390126
[TBL] [Abstract][Full Text] [Related]
54. Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer.
Lucchetti D; Luongo F; Colella F; Gurreri E; Artemi G; Desiderio C; Serra S; Giuliante F; De Maria R; Sgambato A; Vitali A; Fiori ME
Biomed Pharmacother; 2023 Jun; 162():114679. PubMed ID: 37068332
[TBL] [Abstract][Full Text] [Related]
55. Phytochemicals in the Synthetic Era: A Potential Oncosuppressor against Cancer Stem Cells.
Maru D; Kumar A
Anticancer Agents Med Chem; 2023; 23(11):1242-1252. PubMed ID: 36843373
[TBL] [Abstract][Full Text] [Related]
56. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
57. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
58. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
[TBL] [Abstract][Full Text] [Related]
60. Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway.
Sameri S; Saidijam M; Bahreini F; Najafi R
Nutr Cancer; 2021; 73(8):1389-1399. PubMed ID: 32748663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
